Company Directory / Artificial Intelligence (AI)
PrivateFor profitArtificial Intelligence (AI)South Korea
NEUROPHET
NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.
- Founded
- 2016 10 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $48B as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
10 years old.
Reach
Website ranked #5,088,392 in the world for traffic, about 2k visits a month.
What it does
Artificial Intelligence (AI)Machine LearningMedicalNeuroscienceSoftware
Funding, as listed
$48B currency not stated
- Rounds6
- LatestSeries c, Nov 2023
- Investors21, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about NEUROPHET, field by field. Contact details are held but never shown.
The company
- Name
- NEUROPHET
- Type
- For profit
- Status
- Private
- Founded
- 2016
- Founders
- Donghyeon Kim, Junkil Been
- Industry
- Artificial Intelligence (AI)
- Categories
- Artificial Intelligence (AI), Machine Learning, Medical, Neuroscience, Software
Where
- Country
- South Korea
- Markets
- Asia-Pacific (APAC)
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #5,088,392
- Monthly web visits
- 1,575
Funding, as listed
- Total
- 48,000,000,000 (currency not stated)
- Rounds
- 6
- Latest round
- Series c
- Latest round date
- Nov 2023
- Investors
- 21
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
NEUROPHET may be growing as it has recently raised over $35 million, indicating a significant influx of capital that can be used for expansion, research and development, or other growth-related activities. Additionally, the company has attracted investment from Samjin for strategic expansion into the dementia and stroke markets, which suggests an extension of its product applications and potential market reach. The focus on integrating AI into healthcare, as seen in the growing adoption of AI for fall prediction in Singapore, aligns with NEUROPHET's industry and could imply a favorable market environment for the company's growth.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Artificial Intelligence (AI) in South Korea.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 13,309 companies in South Korea and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.